Evaluation of BTX Injections in Treatment of Bruxism
NCT05980559
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Bruxism
Interventions
DRUG:
Xeomin
Sponsor
Alexandria University